NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/20/2023
Back to search
Official data from USPTO
CANCER COPILOT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CANCER COPILOT
ST13
US500000097146450Class
42
Filing
97146450
Registration
7083470
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
06/20/2023
Trademark type
Word
Nice classes
42
Filing date
11/29/2021
Registration date
06/20/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/20/2023
Last transaction
06/20/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
10/23/2014
First use in commerce
10/23/2014
Drawing code
4
Owner type
03
Owner location
New York, NY
Examiner
RYAN, KELLY
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Malecare, Inc.
Representatives
Nadya Munasifi Sand ALSTON & BIRD LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing a website featuring online non-downloadable software that enables cancer patients to track cancer symptomsfind insurance providerslocate physiciansreceive access to peer mentorship and support groupslocate clinical trialsreceive health forms to completeask questions to an automated botidentify payment assistance programs for foodmedicationstransportation and other areas where cancer has a financial impact; providing a website featuring online non-downloadable software that enables patients to use a virtual patient navigator program to find resources for cancer treatment
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/20/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2023
PUBO
PUBLISHED FOR OPPOSITION
04/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/27/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/23/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/23/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/23/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/14/2022
GNRT
NON-FINAL ACTION E-MAILED
09/14/2022
CNRT
NON-FINAL ACTION WRITTEN
09/14/2022
DOCK
ASSIGNED TO EXAMINER
09/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/02/2021
NWAP
NEW APPLICATION ENTERED
12/02/2021
Continuous trademark protection
Get notified about every new filing that threatens CANCER COPILOT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.